Add like
Add dislike
Add to saved papers

Magnetic MnFe 2 O 4 /ZIF-67 nanocomposites with high activation of peroxymonosulfate for the degradation of tetracycline hydrochloride in wastewater.

RSC Advances 2024 Februrary 30
Advanced oxidation processes (AOPs) based on PMS have been used to degrade various refractory pollutants such as drugs, endocrine disruptors, dyes and perfluorinated compounds due to their wide application range, mild reaction conditions, fast reaction rate and simple operation. In this study, tetracycline hydrochloride (TCH) was degraded based on this method. Magnetic MnFe2 O4 /ZIF-67 nanocomposites were successfully prepared by a hydrothermal method, which combined the magnetic separation characteristics of MnFe2 O4 with the high catalytic activity of ZIF-67 and were used to activate peroxymonosulfate (PMS) to efficiently degrade TCH. Satisfactory removal results were obtained with this simple and readily available material, with 82.6% of TCH removed in 15 min. The effect of different conditions on the degradation effect was investigated, and the optimal catalyst concentration and PMS concentration were determined to be 0.1 g L-1 and 0.2 g L-1 , respectively, and all had good degradation effects at pH 5 to 10. XPS, impedance test and radical quenching experiments were used to investigate the degradation mechanism. The results showed that sulfate radical (SO4 - ˙) was the main active species in the degradation process. In addition, the catalyst has good cyclic stability, which provides a new idea for the removal of TCH in wastewater. It is worth mentioning that the catalyst also has good degradation property for other pollutants.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app